
Arthritis is a disease in which inflammation occurs in the joints for some reason, causing persistent chronic swelling and pain. Various types of arthritis, including rheumatoid arthritis and osteoarthritis, can greatly affect daily activities when symptoms progress.
While conventional treatments are aimed at alleviating the symptoms, mainly with pain relief medications, injections, and physiotherapy, it is not easy to regenerate the joint itself.
In recent years, stem cell therapy has attracted attention as a type of regenerative medicine. Stem cells may be used to repair damaged tissues to fundamentally resolve joint pain, decreased range of motion, and other symptoms of arthritis.
In this article, we will reconfirm the causes and symptoms of arthritis and explain the mechanism and benefits of stem cell therapy, as well as the actual treatment process.
Arthritis is a disease associated with pain, swelling, and limited range of motion caused by inflammation occurring in the cartilage, synovium (the membrane that covers the joint), articular capsule, and other joint tissues.
In mild cases, the pain may subside temporarily, but when the condition becomes chronic, the risk of joint deformity greatly interfering with daily life increases. Types of arthritis include the following:
Although the site and mechanism of inflammation differ, in all cases, joint function may be greatly impaired if left untreated. *1
*1 Reference: Maniwa Orthopedic Clinic
While symptoms of arthritis vary depending on the site of inflammation, the following features are common to all types of arthritis.
Pain and swelling may persist chronically and often affect daily living activities (e.g., walking, holding objects). *2
*2 Reference: OMRON
The causes of arthritis are mainly classified as follows:
Once inflammation begins, prompt treatment is necessary to prevent a chronic vicious cycle involving the swelling of the joint capsule and synovium among other symptoms. *3
*3 Reference: Alinamin Pharmaceutical Co., Ltd.
Currently, expectations are focused on stem cells as a treatment approach for arthritis.
Here, we will explain the background of stem cells in relation to the treatment of arthritis and their specific advantages.
Historically, it has been considered difficult to fundamentally regenerate damaged cartilage and bone tissue.
In recent years, stem cell therapy has attracted attention as a type of regenerative medicine that attempts to regenerate damaged cartilage and bone and suppress inflammation, thereby restoring their functions. It offers a new option for treating intractable arthritis, such as osteoarthritis and rheumatoid arthritis.
Stem cell therapy for arthritis is expected to display the following advantages:
The ability to both self-renew and undergo multilineage differentiation allows stem cells to not only compensate for lost cells but also provide an appropriate regenerative environment in the damaged area through secretion of growth factors that activate surrounding tissues, thus exerting a comprehensive effect. In arthritis, pain and functional impairment persist because of continued tissue destruction resulting from the wear and tear of the cartilage and inflammation. Stem cell therapy is expected to support new cartilage formation while suppressing inflammation, thereby increasing the possibility of functional recovery.
However, proper evaluation and explanation by specialists are important because the therapeutic effects of stem cells change depending on the patient’s age, disease stage, degree of joint damage, or other underlying diseases, and cannot be expected to lead to dramatic improvements in all patients.
The Regenerative Medicine Division of Korokai Medical Corporation provides stem cell therapy through the following process in an attempt to improve pain and functional impairment caused by arthritis.
Arthritis is a disease caused by multiple factors such as aging, excessive load, and autoimmune abnormality, and in which cartilage and bone destruction lead to pain and limited range of motion. It is not easy to fundamentally repair the damaged joint tissue. Stem cell therapy has received attention as an innovative means aimed at cartilage and bone regeneration, inflammatory suppression, and pain relief using regenerative medicine approaches. Although there are individual differences in terms of whether patients feel the effects, the therapy holds high promise for fundamental improvements.
The Regenerative Medicine Division of Korokai Medical Corporation offers stem cell-based regenerative medicine as a medical institution approved by the Ministry of Health, Labour and Welfare. *4
If you are interested in stem cell therapy, please contact our hospital for consultation.
The Regenerative Medicine Division of Korokai Medical Corporation carefully selects evidence-based treatment and offers regenerative medicine according to each individual’s concerns based on novel comprehensive treatment strategies. To optimize the results, a combination of oral therapy, such as bioidentical hormone replacement therapy or peptide therapy, and stem cell therapy will be used.
*4 Source: Ministry of Health, Labour and Welfare
________________________________________
[1] Therapeutic Method
The treatment involves harvesting and culturing stem cells from the patient’s adipose tissue and then injecting them locally at the affected area or administering them via intravenous infusion.
[2] Risk of side effects
At the time of fat collection: Adverse reactions such as internal bleeding, swelling, postoperative infection, postoperative scar, and pain at the injection site may be observed.
At the time of stem cell administration: Adverse reactions such as pain at the injection site, allergic reaction, and pulmonary embolism may be observed.
[3] Contact information
The Regenerative Medicine Division, Korokai Medical Corporation
5th floor, Precious 18, 4-14-6 Minami-Azabu, Minato-ku, Tokyo
TEL:03-6277-4650
[4] Pricing
This treatment is a private therapeutic strategy that is not covered by public health insurance.
For culture of approximately 100–180 million stem cells
*Since the number of stem cells that can be grown varies from person to person, it may be less than 100 million stem cells.
1 cycle costs 2.5 million yen (tax included)
3 cycles cost 7.2 million yen (payment in installments: 2.5 million yen each for the first and second cycles, 2.3 million yen for the third cycle)
5 cycles cost 11.5 million yen (tax included) (payment in installments: 2.5 million yen each for the first through fourth cycles, 1.5 million yen for the fifth cycle)
For culture of approximately 200–280 million stem cells
*Since the number of stem cells that can be grown varies from person to person, it may be less than 200 million stem cells.
1 cycle costs 3.8 million yen (tax included)
3 cycles cost 11.1 million yen (tax included) (payment in installments: 3.8 million yen each for the first and second cycles, 3.5 million yen for the third cycle)
5 cycles cost 17.5 million yen (tax included) (payment in installments: 3.8 million yen each for the first through fourth cycle, 2.3 million yen for the fifth cycle)
Please consult us for further details.
[5] Route of acquisition
Stem cells will be cultured at the affiliated CPC.
[6] Presence or absence of devices/drugs approved for the indications in Japan
No approved drugs for the indications are available in Japan.
[7] Safety information from other countries
There are no reports on safety in other countries.
*Significant risks may not have been identified.
[8] The fact that it has not been approved
Drugs used in this treatment are yet to receive approval in accordance with the Pharmaceutical and Medical Device Act.
[9] Unapproved drugs/devices
Public aid systems (such as Relief Systems for Adverse Drug Reactions and Infections Acquired through Biological Products) are not applicable to unapproved drugs and devices.
[10] Notification of regenerative medicine provision plans
To perform this treatment, we have submitted the notification of regenerative medicine provision plans to the Ministry of Health, Labour and Welfare in accordance with the Act on the Safety of Regenerative Medicine.
Ministry of Health, Labour and Welfare, Class 2 Regenerative Medicine Provision Plan No. PB3210146
Ministry of Health, Labour and Welfare, Class 2 Regenerative Medicine Provision Plan No. PB3230187
Ministry of Health, Labour and Welfare, Class 2 Regenerative Medicine Provision Plan No. PB3240017
Ministry of Health, Labour and Welfare, Class 2 Regenerative Medicine Provision Plan No. PB3230218